Cover
Cover | Jan. 05, 2022 |
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Jan. 5, 2022 |
Entity File Number | 001-38630 |
Entity Registrant Name | Aridis Pharmaceuticals, Inc. |
Entity Central Index Key | 0001614067 |
Entity Tax Identification Number | 47-2641188 |
Entity Incorporation, State or Country Code | DE |
Entity Address, Address Line One | 983 University Avenue |
Entity Address, Address Line Two | Bldg. B |
Entity Address, City or Town | Los Gatos |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 95032 |
City Area Code | 408 |
Local Phone Number | 385-1742 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock |
Trading Symbol | ARDS |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | true |
Elected Not To Use the Extended Transition Period | false |